SevenOneSeven Capital Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-770
Closed -$18K 55
2022
Q2
$18K Buy
+770
New +$18.2K 0.04% 50
2021
Q2
Sell
-3,537
Closed -$92K 61
2021
Q1
$92K Buy
3,537
+1,734
+96% +$45.5K 0.34% 47
2020
Q4
$48K Buy
+1,803
New +$47.7K 0.41% 22

Other funds holding IBD

SevenOneSeven Capital Management's IBD Position: Q3 2022 in Review

SevenOneSeven Capital Management sold out of Inspire Corporate Bond ETF (IBD) in Q3 2022, closing a stake of 770 shares — an estimated $18K sold.

SevenOneSeven Capital Management first reported a position in IBD in Q4 2020 and held it in 3 quarters. The position peaked at $92K in Q1 2021. 52 funds tracked by Wall St. Rank hold IBD as of Q3 2022.

  • SevenOneSeven Capital Management reported no remaining Inspire Corporate Bond ETF position as of Q3 2022 after selling out during the quarter.
  • SevenOneSeven Capital Management sold 770 Inspire Corporate Bond ETF shares in Q3 2022, an estimated $18K.
  • SevenOneSeven Capital Management first reported a position in Inspire Corporate Bond ETF in Q4 2020 and held it in 3 quarters.
  • SevenOneSeven Capital Management's Inspire Corporate Bond ETF position peaked at $92K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2022.

Based on SevenOneSeven Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.